Periostin, a matricellular adapter protein highly expressed by periodontal ligament fibroblasts, is implicated in the maintenance of periodontal integrity, which is compromised during periodontal diseases. The aim of this study was to explore the influence of chronic periodontal inflammation on tissue periostin levels. Periodontal breakdown was induced in a pre-clinical ligature periodontal inflammatory disease model. Periodontal tissue specimens were harvested at baseline, 2 weeks, and 4 weeks and prepared for histologic, immunofluorescence, and micro-CT examination. Statistical analyses were conducted by Kruskal-Wallis, Mann-Whitney, and Spearman's tests. Periostin detection levels were reduced over time in response to the inflammatory process (1 ± 0.05; 0.67 ± 0.03; 0.31 ± 0.02; p < 0.001; baseline, 2, and 4 weeks, respectively). Simultaneously, alveolar bone loss increased from baseline to the 2-and 4-week time-points (0.40 ± 0.02 mm; 1.39 ± 0.08 mm; 1.33 ± 0.15 mm; p < 0.001), which was inversely correlated with the levels of periostin (ρ = -0.545; p < 0.001). In conclusion, periostin PDL tissue levels significantly decrease under chronic inflammatory response and correlate with the detrimental changes to the periodontium over time.
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IntrODuctIOn
L oss of tooth-supporting structures affects up to 90% of the general worldwide adult population experiencing different types of periodontal diseases (Papapanou, 1996) and constitutes the primary cause of tooth loss in adults aged 35 yrs and over (Niessen and Weyant, 1989) . Periodontal diseases are induced by bacteria acting in a susceptible host (Page and Kornman, 1997) . Different molecules act in this scenario, reflecting periodontal bone loss activity and susceptibility. However, because this is a highly complex disease, it is unlikely that a single biomarker for disease detection and prediction can be found (Kinney et al., 2011) .
During periodontal homeostasis and healing, cell turnover, recruitment, and differentiation are tightly regulated processes. In this context, matricellular molecules within the periodontal ligament (PDL) aim to stabilize the extracellular matrix (ECM) for supporting mechanical and biological challenges. They act by providing signals to the constituent cell populations to modulate their phenotype to maintain tissue homeostasis. In that sense, periostin (gene POSTN), a secreted adhesion molecule highly expressed in the PDL, is essential for periodontal tissue integrity. It also plays an important role in tooth development and eruption processes (Kruzynska-Frejtag et al., 2004; Rios et al., 2005 Rios et al., , 2008 . Furthermore, periostin expression is increased in response to occlusal loading and orthodontic movement (Wilde et al., 2003; Afanador et al., 2005) . Its presence in the ECM is induced by biomechanical stimuli via TGF-ß1 signaling (Rios et al., 2008; Wen et al., 2010) . Once secreted, it modulates the matrix-cell interactions relevant to connective tissue repair and remodeling, fibroblast attachment and spreading (Hamilton, 2008; Hoersch and Andrade-Navarro, 2010) , and activation of cell survival signaling pathways (Bao et al., 2004) . Periostin influences mechanical stability and tissue strength by regulating collagen fibrillogenesis (Norris et al., 2007) . Moreover, it has been recently used as a marker to investigate the functional integrity of a regenerated PDL interface (Park et al., 2012) . In contrast, reduction or absence of POSTN in KO mice leads to periodontal breakdown in a periodontal-disease-like process once occlusal loading starts after teeth eruption (Rios et al., 2005 (Rios et al., , 2008 . These properties highlight its key role during periodontal homeostasis, maintaining a healthy tooth-supporting apparatus against biomechanical challenges.
However, reductions in periostin levels as a co-factor for periodontal destruction and breakdown have not been yet studied in vivo. Therefore, the aim of this study was to explore the influence of spatial and temporal periodontal inflammation on the levels of the matricellular adapter protein Periostin is Down-regulated during Periodontal Inflammation periostin over time in an inflammatory-induced periodontal disease animal model. Accordingly, disease progression in terms of linear and volumetric bone changes, periostin levels, and inflammatory process was analyzed.
MAtErIALs & MEthODs

Experimental Design
All animal procedures were approved by the University of Michigan Committee of Use and Care of Animals. Thirty male Sprague-Dawley rats (weight, 250-300 g each) were assigned to 3 equal experimental groups: control group at the time of ligature placement (baseline); animals subjected to disease induction for 2 wks; and animals subjected to disease induction for 4 wks.
Ligature-induced Periodontal Disease
Sprague-Dawley rats were anesthetized via intraperitoneal injections of a ketamine and xylazine cocktail (Rios and Giannobile, 2011) . Silk sutures (4/0) were secured around the cervical parts of the right maxillary first and second molar teeth and placed in the gingival sulci. The ligatures were evaluated twice weekly, gently displaced apically into the gingival sulci to ensure a subgingival position, and replaced when dislodged or lost.
Quantitative Micro-ct Analysis
Block biopsies were harvested at each time-point. Rat mandible specimens were fixed in a 10% buffered formalin phosphate solution for 1 day and scanned by micro-CT (eXplore Locus SP, GE Healthcare Inc., London, ON, Canada) with 18 × 18 × 18 μm 3 voxel size. Linear alveolar bone loss (ABL; mm) was determined in the interproximal area between the first and second molars by measurement of the distance from the cementoenamel junction (CEJ) to the alveolar bone crest (ABC). After the teeth were digitally removed, regions of interest (ROI) for the assessment of mineralized tissue volume were created with the same size in the interproximal area between the first and second molars , extending from the apical end of the roots to the CEJ (Fig. 1A) . Based on the HU grayscale level, bone volume (BV; mm 3 ), and bone mineral density [BMD; mg (HyAp)/cc] were quantified. MicroView Analysis+ 2.1.2 software (GE Healthcare) was used to perform these analyses. All measurements were repeated 2 times per site, and the mean value was recorded.
histologic and Immunofluorescence Analyses
After the μCT scanning, the harvested mandibles were decalcified with 10% ethylene diaminetetraacetic acid (EDTA; Sigma-Aldrich Co. LLC, St. Louis, MO, USA) for 4 wks and embedded in paraffin blocks for histological sectioning. Hematoxylineosin staining was used to evaluate bone destruction and softtissue changes.
Polymorphonuclear neutrophils (PMNs) and T-lymphocytes in the area were evaluated by immunohistochemical staining for myeloperoxidase and CD3, respectively. Briefly, after an antigen retrieval pre-treatment (citrate buffer, pH 6.0, boiled for 10 min), CD3 (1:200 dilution; ab5690, Abcam, Inc., Cambridge, MA, USA) and myeloperoxidase (1:250 dilution; ab45977, Abcam) primary antibodies were incubated for 30 min, followed by the addition of secondary antibodies (30 min), DAB staining (5 min), and hematoxylin counterstain (1 min) in an autostainer (EnVision+ protocol; Dako North America, Inc., Carpinteria, CA, USA). Sections were then dehydrated and covered with a glass coverslip. The ApopTag Kit (S7100; EMD Millipore Corporation, Billerica, MA, USA) was used to detect apoptotic cells. Three blinded examiners analyzed a total of 8 digital sections of each group and each staining (original magnification of 20X). Regions of interest measuring 200 x 300 μm were established in an apical direction from the most coronal contact between the soft tissue and the tooth surface, and positive cells were counted.
We also performed immunofluorescence staining to periostin on paraffin sections by using an affinity-purified rabbit polyclonal antibody (1:400 dilution; ab14041 Abcam). Immunological reaction was visualized by the use of a sheep polyclonal secondary antibody to rabbit conjugated with Texas Red™ (1:200 dilution; ab6793-1, Abcam). The sections were then treated with an anti-fade agent containing 4′,6-diamidino-2-phenylindole (DAPI) (ProLong ® Gold anti-fade reagent with DAPI; Invitrogen, Life Technologies Corporation, Grand Island, NY, USA) and covered with a glass coverslip. The stained slides were imaged with an OLYMPUS Fluoview 500 confocal microscope (Olympus America Inc., Center Valley, PA, USA) at constant settings. ImageJ (National Institutes of Health, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/) was used to analyze the periostin fluorescence intensity. Briefly, areas to be analyzed extended from the ABC to the apex of the root, non-PDL areas were digitally subtracted, the entire figure was quantitatively mapped, and a mean fluorescent light intensity value was obtained and adjusted to total PDL area per image. All values were normalized to baseline. ImageJ was also used to represent the periostin intensity in a pseudo-3D figure (heat-map).
statistical Analysis PASW Statistics 18.0 (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses. All data are presented as the mean value ± SEM (standard error of the mean). The significance of the differences among groups was determined by the Kruskal-Wallis test (α = 0.05), since the population was not normally distributed (p < 0.05, Shapiro-Wilk test). The Mann-Whitney U test was used to define pairwise statistical differences with Bonferroni correction (α = 0.0167). Spearman's rank coefficient (α = 0.05) was used to demonstrate any correlations between variables.
rEsuLts
Linear and Volumetric Analyses ABL (mm) was significantly different among groups (p < 0.001; Kruskal-Wallis). ABL in the baseline group (0.40 ± 0.02) was significantly lower than that in the diseased groups at both 2 (1.39 ± 0.08; p < 0.001; Mann-Whitney) and 4 wks (1.33 ± 0.15; p < 0.001; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.364) (Figs. 1A, 1B) .
Consistently, volumetric analysis (BV, mm 3 ) revealed a significant difference among groups (p < 0.001; Kruskal-Wallis). Baseline levels (0.77 ± 0.03) were significantly higher than those in disease at 2 (0.39 ± 0.04; p < 0.001; Mann-Whitney) and 4 wks (0.37 ± 0.04; p < 0.001; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.762; Mann-Whitney). BMD (mg/cc) was also significantly different among groups (p < 0.002; Kruskal-Wallis), being significantly higher at baseline (198.61 ± 24.69) compared with that in disease at 2 (75.07 ± 21.31; p < 0.003; Mann-Whitney) and 4 wks (97.58 ± 11.64; p < 0.002; Mann-Whitney). No significant difference was found between the 2 diseased groups (p = 0.199; Mann-Whitney) (Figs. 1A, 1C ).
Evaluation of the Inflammatory Process
Histological analysis demonstrated a high impact on PDL tissue structure over time ( Figs. 2A, 3A) . In the baseline group, a wellorganized PDL tissue was observed. ABC looked normal, without major Howship's lacunae. PDL and gingival fibers showed a regular orientation from bone to tooth. In contrast, the 2-week group showed a disorganized PDL fiber orientation, and inflammatory infiltrated and reduced ABC, with those detrimental effects being even more evident for the 4-week group. Specific immunohistochemical analyses showed a statistically significant increase of myeloperoxidase-(2.63 ± 0.65, 27.57 ± 4.69, 38.17 ± 9.74) (Figs. 2B, 2E ) and CD3-positive cells (4.5 ± 1.02, 19.71 ± 3.08, 33.86 ± 4.06) (Figs. 2C, 2F) as well as apoptotic cells (2.0 ± 0.57, 30.86 ± 5.26, 64.5 ± 8.05) (Figs. 2D, 2G) from baseline to 2 and 4 wks (p < 0.001, Mann-Whitney). From 2 to 4 wks, CD3 and apoptotic positive cells increased significantly (p < 0.011 and p < 0.008, Mann-Whitney, respectively), but not myeloperoxidase (p = 0.534, Mann-Whitney).
Periostin Levels
Periostin fluorescence intensity levels were significantly reduced over time by the effect of the inflammatory process induced by the ligature (p < 0.001; Kruskal-Wallis) (Figs. 3B, 3C) . At baseline (1.0 ± 0.05), relative periostin levels were significantly higher than those in diseased groups at both 2 (0.67 ± 0.03; p < 0.001; Mann-Whitney) and 4 wks (0.31 ± 0.02; p < 0.001; Mann-Whitney). The difference between the 2-and 4-week groups was also statistically significant (p < 0.001; Mann-Whitney) (Fig. 3D ).
correlation between Levels of Periostin and bone Destruction
Ligature-induced periodontal inflammation resulted in clear correlation of periostin levels and detrimental changes to the periodontium over time, at linear (ABL-periostin, r 2 linear = 0.681; ρ = −0.545, p < 0.001, Spearman) ( Fig. 4A) , volumetric (BV-periostin, r 2 linear = 0.762; ρ = 0.642, p < 0.001, Spearman), and mineral density levels (BMD-periostin, r 2 linear = 0.565; ρ = 0.411, p < 0.012, Spearman) (Fig. 4B) . Areas with lower levels of periostin corresponded to the areas where more coronalapical detrimental tissue changes were noticeable (higher ABL, lower BV and BMD).
DIscussIOn
New insights into the pathogenesis of periodontitis incorporate gene, protein, and metabolite data into dynamic biological networks that include diseaseinitiating and progression mechanisms. Periostin as a modulator of critical matricellular interactions is relevant in those processes.
Of the known proteins expressed in the PDL, periostin shows the greatest specificity (Saito et al., 2002) . It is localized between the cytoplasmic processes of periodontal fibroblasts and cementoblasts and the adjacent collagen fibrils (Suzuki et al., 2004) . In those areas, periostin is closely related to the PDL fiber bundles from the rootsurface cementum to the alveolar bone engaging the tooth-supporting apparatus and reflecting a mature and stable tissue (Park et al., 2012) .
In contrast, periostin deletion induces a reduction in collagen fiber diameter that results in a decreased tissue modulus of elasticity (Norris et al., 2007) . In the case of periostin KO mice, the periodontal ligament is unable to sustain the normal physiological occlusal load, which results in a rapid deterioration of the functional and structural integrity of the periodontium: advanced alveolar bone loss, severe clinical attachment loss, and significant widening of the PDL region (Rios et al., 2005 (Rios et al., , 2008 Ma et al., 2011) . In the present study, the inflammatory process initiated by the ligature placement was able to induce a periostin reduction that was correlated with bone loss. This collateral effect of inflammation on periostin expression directly compromised the integrity of the PDL, favoring an inappropriate response to traumatic or even normal occlusal forces, ultimately leading to bone destruction and periodontal breakdown.
No significant differences in ABL, BV, or BMD were observed within the 2-and 4-week time-points, which is consistent with results of previous studies Pellegrini et al., 2009; Rios and Giannobile, 2011) . However, the levels of periostin were reduced from 2 to 4 wks. This observation may lead to subsequent bursts of periodontal destruction due to changes in the PDL tissue strength and ability to respond to mechanical challenges (Norris et al., 2007) . Periostin is primarily expressed within the PDL region by PDL fibroblasts (Saito et al., 2002) . Therefore, the decrease in periostin levels reflects the loss of PDL tissue integrity, which might be due to a switch from a well-organized PDL to an inflammatory infiltrated tissue. Analysis of our data shows a significant increase in T-lymphocytes (CD3-positive cells) and apoptotic cells at 4 wks vs. baseline and 2 wks. An initial significant increase in PMNs (myeloperoxidasepositive cells) was observed but not maintained from 2 to 4 wks. This scenario reflects an inflammation profile toward a more stable, yet chronic, inflammatory infiltrated tissue. Some studies have suggested an increase of periostin detection in other chronic pathological conditions, leading to a fibrotic situation (Hakuno et al., 2010; Daines et al., 2011; Uchida et al., 2012) . Our results may indicate a different periostin expression pattern in periodontal diseases. When those differences are analyzed, the specific periodontal environment (bacterial contamination, mechanical requirements, etc.) must be considered. Based on our in vitro studies, the expression of periostin is specifically reduced in human PDL fibroblasts by the effects of inflammatory cytokines and bacterial by-products (Padial-Molina et al., Epub ahead of print). However, it is important to highlight that two overlapping scenarios could support the altered levels of periostin in the chronically inflamed periodontium: (1) Bacterial/ inflammatory challenge could lead to decreased periostin produced by PDL fibroblasts, and (2) a decrease in the number of PDL fibroblasts could explain the lower periostin levels. Both scenarios represent an important observation with significant clinical implications that compromise the function and structure of the periodontium. When periostin is reduced or completely depleted, the stability of the PDL is compromised, and it is more susceptible to injury and the subsequent inflammatory process, since the structural and biomechanical capacities are reduced (Rios et al., 2005 (Rios et al., , 2008 . Therefore, the in vivo reduction of periostin in our periodontal inflammatory model occurs not only due to the changes in the PDL tissue (i.e., from an organized, specialized, and competent tissue to a chronic inflammatory infiltrated tissue, which contains less competent PDL fibroblasts capable of expressing periostin), but also due to a direct effect of the inflammatory molecular environment around the main periostin expressers (i.e., PDL fibroblasts). This inflammatory environment could further increase the pathological changes as tissue mechanical properties decrease. Such mechanisms support our present in vivo results and favor the idea of a complex regulatory pathway of periodontal tissue homeostasis where periostin is a key factor for maintaining tissue integrity under biomechanical, bacterial, and inflammatory challenges.
Periostin, a key factor for periodontal stability, is reduced as a consequence of inflammatory-induced periodontal disease. Periostin could represent a novel biological agent with significant potential for diagnostic and susceptibility assessment purposes. It could add supporting scientific information to capture the dynamic nature of the matricellular biochemical events involved in the transition between periodontal health and disease. Further studies of the diagnostic value of periostin as a marker for disease activity and susceptibility in humans, to confirm our in vitro and animal studies, are needed and have already been initiated by our group (clinicaltrials.gov Id #: NCT01180920).
